Skip to main content

VERORAB (Sanofi-Aventis Australia Pty Ltd)

Product name
Date registered
Evaluation commenced
Decision date
Approval time
210 (255 working days)
Active ingredients
Rabies virus
Registration type

VERORAB is indicated for pre-exposure prophylaxis against rabies.

VERORAB is indicated for post-exposure prophylaxis against rabies.

VERORAB should be used in accordance with official local recommendations.

Help us improve the Therapeutic Goods Administration site